Oxford Biotherapeutics

Oxford BioTherapeutics is a pioneering biotechnology company based in San Jose, CA, focused on developing first-in-class cancer therapies through innovative targeted approaches, including Antibody-Drug Conjugates and Immuno-oncology T-Cell Engagers. With a mission to transform cancer treatment and improve patient outcomes globally, the company utilizes its proprietary OGAP-Verify platform to identify novel cancer targets and advance strategic partnerships within the industry.

With a dynamic team of over 500 employees, Oxford BioTherapeutics is committed to driving progress in oncology through a fully integrated discovery and development workflow. Their portfolio includes a diverse range of clinical-stage assets and a robust pipeline of novel cancer-specific targets, reflecting their dedication to addressing unmet medical needs in cancer treatment.

Generated from the website